Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer at what cost?

[1]  D. Appleton,et al.  A protective effect of sulindac against chemically‐induced primary colonic tumours in mice , 1988, The Journal of pathology.

[2]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[3]  C. Smart Screening and early diagnosis , 1992, Cancer.

[4]  O. Terpstra,et al.  Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. , 1987, Gastroenterology.

[5]  L F Watson,et al.  Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.

[6]  C. Torrance,et al.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.

[7]  J. F. Fraumeni,et al.  Incidence of cancer among patients with rheumatoid arthritis. , 1993, Journal of the National Cancer Institute.

[8]  M. Langman,et al.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. , 1985, British medical journal.

[9]  S. Shapiro,et al.  Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. , 1988, Archives of internal medicine.

[10]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[11]  J. Bordas,et al.  Effects of long-term sulindac therapy on colonic polyposis. , 1991, Annals of internal medicine.

[12]  J. Manson,et al.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial. , 1993, Journal of the National Cancer Institute.

[13]  T. Hanlon Major upper gastrointestinal tract bleeding: Relation to the use of aspirin and other nonnarcotic analgesics , 1988 .

[14]  T. Kudo,et al.  Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. , 1981, Cancer research.

[15]  P. Greenwald Colon cancer overview , 1992, Cancer.

[16]  J. Kurata,et al.  The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. , 1990, Journal of clinical gastroenterology.

[17]  D. Ahlquist,et al.  Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. , 1992, Mayo Clinic proceedings.

[18]  M. Odeh,et al.  Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. , 1990, The American journal of gastroenterology.

[19]  N. Petrelli,et al.  Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.

[20]  J. Baron,et al.  Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.

[21]  D. McCarthy,et al.  Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. , 1991, Annals of internal medicine.

[22]  J. Baron,et al.  Prospects for preventing colorectal cancer death. , 1993, Journal of the National Cancer Institute.

[23]  H. A. Gardner,et al.  Letter: Confirmation of antenatally detected trisomy-D from saline aborted products of conception. , 1974, Lancet.

[24]  S. Skinner,et al.  Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. , 1991, Archives of surgery.

[25]  W. Waddell,et al.  Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.

[26]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[27]  D. Graham,et al.  Aspirin and the stomach. , 1986, Annals of internal medicine.

[28]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[29]  E. Cerise,et al.  Sulindac for polyposis of the colon. , 1989, American journal of surgery.

[30]  C. Hawkey,et al.  Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. , 1989, BMJ.

[31]  S. Shankel,et al.  Effects of Nonsteroidal Anti-Inflammatory Drugs on Prostaglandins and Renal Function , 1985 .

[32]  S. Gabriel,et al.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.

[33]  J. G. Lewis,et al.  Screening and Diagnosis , 1964 .

[34]  G. Kelloff,et al.  Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.

[35]  M. Iida,et al.  Treatment of desmoid tumors in Gardner's syndrome , 1988, Diseases of the colon and rectum.

[36]  Morris Pollard,et al.  Treatment of Chemically-Induced Intestinal Cancers with Indomethacin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  F. DeRubertis,et al.  Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. , 1992, Carcinogenesis.

[38]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[39]  J. Buring,et al.  Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. , 1991, The American journal of gastroenterology.

[40]  D. Eddy,et al.  Screening for colorectal cancer , 1992, The Lancet.

[41]  J. Travers,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.

[42]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[43]  E. Whitacre,et al.  Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. , 1992, Archives of internal medicine.

[44]  Silvestre Carneiro,et al.  SULINDAC TREATMENT FOR FAMILIAL POLYPOSIS COLI , 1985, The Lancet.

[45]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[46]  Renal syndromes associated with non-steroidal anti-inflammatory drugs , 1984 .